AZ Sint-Lucas

Ghent, Belgium

10 recruiting

Showing 119 of 19 trials

Recruiting
Phase 2Phase 3

Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis

End-stage Kidney DiseaseAtherosclerotic Cardiovascular DiseaseAtherosclerotic Cardiovascular Disease in Patients With ESKD
CSL Behring2,310 enrolled542 locationsNCT05485961
Recruiting
Phase 3

A Study to Test Whether Vicadrostat (BI 690517) in Combination With Empagliflozin Helps People With Heart Failure and a Weak Pumping Function of the Left Side of the Heart

Heart Failure
Boehringer Ingelheim4,200 enrolled638 locationsNCT06935370
Recruiting
Phase 3

A Study to Test Whether Vicadrostat in Combination With Empagliflozin Helps People With Heart Failure

Heart Failure
Boehringer Ingelheim6,000 enrolled653 locationsNCT06424288
Recruiting
Phase 3

This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide Will Work Better Than Taking Enzalutamide Alone in Participants With mCSPC Who Are ARPI naïve.

Prostate CancerCancer of the ProstateHormone Sensitive Prostate Cancer+1 more
Pfizer1,000 enrolled295 locationsNCT07028853
Recruiting
Phase 3

Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer

Colorectal NeoplasmsNeoplasms by SiteGastrointestinal Neoplasms+7 more
Pfizer800 enrolled156 locationsNCT07222800
Recruiting

RELIEF - A Global Prospective Observational Post-Market Study to Evaluate Long-Term Effectiveness of Neurostimulation Therapy for Pain

Pain
Boston Scientific Corporation4,800 enrolled118 locationsNCT01719055
Recruiting

Registry of Deep Brain Stimulation With the VERCISE™ System: Vercise DBS Registry

Parkinson's Disease
Boston Scientific Corporation1,500 enrolled84 locationsNCT02071134
Recruiting

Boston Scientific Registry of Deep Brain Stimulation for Treatment of Essential Tremor (ET)

Essential Tremor
Boston Scientific Corporation500 enrolled20 locationsNCT04032470
Recruiting

Vercise™ DBS Dystonia Prospective Study

Dystonia
Boston Scientific Corporation300 enrolled36 locationsNCT02686125
Recruiting
Phase 3

Study of TDXd, Chemotherapy, Pembrolizumab, and Trastuzumab in First-Line Metastatic HER2-Positive Gastric or Gastroesophageal Junction Cancer

Gastric CancerGastroesophageal-junction Cancer
Daiichi Sankyo726 enrolled250 locationsNCT06731478
Recruiting
Phase 3

Study of Trastuzumab Deruxtecan With Bevacizumab Versus Bevacizumab Monotherapy for First-line Maintenance in HER2-Expressing Ovarian Cancer (DESTINY-Ovarian01)

Ovarian Cancer
Daiichi Sankyo582 enrolled180 locationsNCT06819007
Recruiting
Not Applicable

Achieving a Better Outcome Through Limiting the Glioblastoma Clinical Target Volume

Radiotherapy Side EffectGlioblastoma
Cliniques universitaires Saint-Luc- Université Catholique de Louvain347 enrolled23 locationsNCT06719440
Recruiting
Not Applicable

Synbiotics in Patients at RIsk fOr Preterm Birth

Microbial ColonizationPreterm BirthPreterm Spontaneous Labor With Preterm Delivery+3 more
Ziekenhuis Oost-Limburg402 enrolled9 locationsNCT05966649
Recruiting
Phase 3

A Study of Nipocalimab Administered to Adults With Generalized Myasthenia Gravis

Myasthenia Gravis
Janssen Research & Development, LLC199 enrolled112 locationsNCT04951622
Recruiting
Phase 3

Intra-arterial Gemcitabine vs. IV Gemcitabine and Nab-Paclitaxel Following Radiotherapy for LAPC

Locally Advanced Pancreatic Cancer
RenovoRx190 enrolled42 locationsNCT03257033
Recruiting

The Epidemiology of Suicide Attempts and Suicidal Thoughts in Flanders

Suicidal IdeationMulticenter StudySuicidal Behavior+2 more
University Hospital, Ghent50,000 enrolled33 locationsNCT07021404
Recruiting
Phase 3

ProBio: A Biomarker Driven Study in Patients With Metastatic Prostate Cancer

Metastatic Castration-resistant Prostate Cancer (mCRPC)Metastatic Hormone-Sensitive Prostate Cancer (mHSPC)
Karolinska Institutet750 enrolled32 locationsNCT03903835
Recruiting
Not Applicable

Therapeutic Drug Monitoring of Brodalumab in Psoriasis Patients (BIOLOPTIM-BRO)

Psoriasis Vulgaris
University Hospital, Ghent100 enrolled7 locationsNCT04080635
Recruiting
Not Applicable

Follow-up and Outcome of Operative Treatment With Decompressive Release Of The Peroneal Nerve

Peroneal Nerve Entrapment
Universitaire Ziekenhuizen KU Leuven182 enrolled18 locationsNCT04695834